Market Overview

Benzinga's Top Initiations

Related RPRX
Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline
UPDATE: Ascendiant Capital Markets Reiterates On Repros Therapeutics Following Positive Topline Results

Analysts at Lazard Capital initiated coverage on shares of Repros Therapeutics (NASDAQ: RPRX) with a “buy” rating. The target price for Repros Therapeutics is set to $26. Repros Therapeutics' shares closed at $11.83 yesterday.

Citigroup initiated coverage on shares of Workday (NYSE: WDAY) with a “neutral” rating. The target price for Workday is set to $58. Workday's shares closed at $52.61 yesterday.

Wedbush initiated coverage on shares of Denny's (NASDAQ: DENN) with an “outperform” rating. The target price for Denny's is set to $6. Denny's stock closed at $4.98 yesterday.

Analysts at Credit Suisse initiated coverage on shares of Williams-Sonoma (NYSE: WSM) with a “neutral” rating. The target price for Williams-Sonoma is set to $49. Williams-Sonoma's shares closed at $44.90 yesterday.

Latest Ratings for RPRX

DateFirmActionFromTo
Sep 2014Piper JaffrayDowngradesOverweightNeutral
Nov 2013Piper JaffrayInitiates Coverage onOverweight
Nov 2013Laidlaw & Co.Initiates Coverage onBuy

View More Analyst Ratings for RPRX
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (DENN + RPRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters